• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Celgene Corporation (CELG)

    -NasdaqGS
    118.47 Down 1.84(1.53%) Mar 3, 4:00PM EST
    |After Hours : 118.01 Down 0.46 (0.39%) Mar 3, 7:49PM EST
    Add to Portfolio
    Prev Close:120.31
    Open:120.00
    Bid:N/A
    Ask:118.87 x 100
    1y Target Est:137.54
    Beta:1.77
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:116.34 - 120.19
    52wk Range:66.85 - 125.45
    Volume:6,360,692
    Avg Vol (3m):5,655,940
    Market Cap:94.85B
    P/E (ttm):49.57
    EPS (ttm):2.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 1.53%94.85B
    JNJDown 0.85%284.56B

    Key Statistics

    Forward P/E (1 yr):18.77
    P/S (ttm):12.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.83
    Quarterly EPS Est (Mar-15) :1.07
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback